Last Updated: June 23, 2026

COLESEVELAM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Colesevelam, and what generic alternatives are available?

Colesevelam is a drug marketed by Alkem Labs Ltd, Glenmark Pharms Ltd, Impax, Watson Labs Inc, Beijing Tide Pharm, Bionpharma, Chartwell Rx, Dr Reddys, Impax Labs Inc, Invagen Pharms, Inventia, Macleods Pharms Ltd, United Res Labs, Zhejiang Jingxin, and Zydus Pharms. and is included in eighteen NDAs.

The generic ingredient in COLESEVELAM is colesevelam hydrochloride. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the colesevelam hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Colesevelam

A generic version of COLESEVELAM was approved as colesevelam hydrochloride by IMPAX LABS INC on May 16th, 2018.

  Start Trial

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for COLESEVELAM?
  • What are the global sales for COLESEVELAM?
  • What is Average Wholesale Price for COLESEVELAM?
Summary for COLESEVELAM
US Patents:0
Applicants:15
NDAs:18
Drug Prices: Drug price information for COLESEVELAM
DailyMed Link:COLESEVELAM at DailyMed
Drug patent expirations by year for COLESEVELAM
Drug Prices for COLESEVELAM

See drug prices for COLESEVELAM

US Patents and Regulatory Information for COLESEVELAM

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem Labs Ltd COLESEVELAM HYDROCHLORIDE colesevelam hydrochloride FOR SUSPENSION;ORAL 210316-001 May 6, 2019 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Watson Labs Inc COLESEVELAM HYDROCHLORIDE colesevelam hydrochloride TABLET;ORAL 200830-001 Sep 2, 2020 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Alkem Labs Ltd COLESEVELAM HYDROCHLORIDE colesevelam hydrochloride TABLET;ORAL 209038-001 Oct 5, 2018 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Impax COLESEVELAM HYDROCHLORIDE colesevelam hydrochloride FOR SUSPENSION;ORAL 212886-001 Jan 18, 2023 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Glenmark Pharms Ltd COLESEVELAM HYDROCHLORIDE colesevelam hydrochloride TABLET;ORAL 203480-001 May 18, 2018 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Zydus Pharms COLESEVELAM HYDROCHLORIDE colesevelam hydrochloride TABLET;ORAL 207765-001 Oct 7, 2019 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

DrugChatter Q&A for COLESEVELAM
Colesevelam hydrochloride production cost?
Colesevelam 625mg tablets?
Colesevelam hydrochloride brand name?
Colesevelam 625 mg tablet price?
Colesevelam 625 mg tablet brand name?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links